Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Alnylam Pharmaceuticals Inc. logo

Alnylam Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

145.79
 
USD
  
1.38
  
(0.96%)
Optionable: Yes  Market Cap: 18,479 M  90-day average vol: 849,169

Previous close: 144.41  Open: 145.21  Bid: 141.0  Ask: 151.23
52 week range    
143.50   
   218.88
Peers   
ARWR / 
REGN / 
SRPT / 
OPK / 
SNY / 
RGLS / 
NVS / 
Last updated: Tuesday 23rd April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ARWR

6 B-38.852.1

NVS

OPK

2 B27.83.26

REGN

66 B9.7622.36

RGLS

0 B-10.2408

SNY

SRPT

6 B-11.775.95

TEVA

Financials

ALNY Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-4.85-3.45-4.79-7.57-8.11-7.46-7.2-9.3-3.52
Basic EPS total-4.85-3.45-4.79-7.57-8.11-7.46-7.2-9.3-3.52
Basic weighted shares outstanding74 M84 M86 M91 M101 M109 M115 M118 M122 M125 M
Cost of sales590 M2 M25 M74 M115 M140 M268 M
Depreciation5 M7 M10 M12 M13 M17 M30 M37 M39 M52 M
DepreciationAndAmortization5 M7 M10 M12 M13 M17 M30 M37 M39 M52 M
DevelopmentExpense221 M
Diluted EPS total-4.85-3.45-4.79-5.42-7.57-8.11-7.46-7.2-9.3-3.52
Diluted normalized net income/share-7.2-9.3-3.52
Diluted weighted shares outstanding74 M84 M86 M91 M101 M109 M115 M118 M122 M125 M
GainOnSaleOfSecurity3 M6 M8 M12 M29 M33 M
GeneralAndAdministrativeExpense45 M61 M89 M199 M382 M479 M588 M621 M771 M796 M
Gross operating profit51 M41 M47 M90 M73 M195 M419 M729 M897 M1,560 M
Income before tax-401 M-290 M-410 M-491 M-761 M-885 M-856 M-852 M-1,127 M-434 M
Income taxes-40 M823000.0863000.03 M680000.04 M7 M
Interest income33 M12 M2 M25 M96 M
InterestExpenseNonOperating84 M143 M156 M121 M
MiscOtherSpecialCharges2 M76000.06 M-3 M4 M21 M46 M-471000.0-211 M-126 M
Net income from total operations-360 M-290 M-410 M-491 M-761 M-886 M-858 M-853 M-1,131 M-440 M
NetIncomeCommonStockholders-360 M-290 M-410 M-491 M-761 M-886 M-489 M-853 M-1,131 M-440 M
NetIncomeContinuousOperations-360 M-290 M-410 M-491 M-761 M-886 M-858 M-853 M-1,131 M-440 M
NetNonOperatingInterestIncomeExpense12 M33 M-73 M-143 M-131 M-26 M
NonRecurringOperationExpense-21 M
Normalized income-441 M-189 M-267 M-319 M-621 M-699 M-676 M-342 M
Operating income-405 M-296 M-425 M-500 M-815 M-939 M-828 M-709 M-785 M-282 M
Operating income before depreciation (EBITDA)-389 M-271 M-395 M-491 M-761 M-848 M-731 M-667 M-930 M-269 M
OperatingExpense456 M337 M472 M590 M888 M1,134 M1,243 M1,413 M1,654 M1,800 M
Other income net-4 M-6 M-14 M-9 M-33 M-21 M-46 M471000.0211 M126 M
OtherGandA45 M61 M89 M199 M382 M479 M588 M621 M771 M796 M
OtherOperatingExpenses456 M337 M472 M-590 M54 M53 M64 M63 M67 M
RentAndLandingFees9 M11 M16 M19 M41 M52 M
Research & development expense411 M276 M382 M391 M505 M655 M655 M792 M883 M1,004 M
ResearchExpense190 M276 M382 M391 M505 M655 M655 M792 M883 M1,004 M
SalariesAndWages33 M46 M76 M93 M158 M3 M571000.03 M4 M4 M
Selling Gen & administrative expense45 M61 M89 M199 M382 M479 M588 M621 M771 M796 M
Special income/charges21 M
Total Income available for interest expense (EBIT)-401 M-290 M-410 M-491 M-761 M-885 M-771 M-709 M-971 M-312 M
Total common shares outstanding84 M85 M86 M100 M106 M113 M117 M124 M126 M
Total net income-360 M-290 M-410 M-491 M-761 M-886 M-858 M-853 M-1,131 M-440 M
Total ordinary shares126 M126 M126 M126 M126 M126 M126 M126 M126 M126 M
Total revenues51 M41 M47 M90 M75 M220 M854 M1,508 M1,037 M1,828 M
TotalExpenses456 M337 M472 M1,180 M890 M1,159 M1,317 M1,528 M1,794 M2,068 M
TotalRevenue51 M41 M47 M90 M75 M220 M493 M844 M1,037 M1,828 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University